The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in ...
The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...
US FDA issues guidance on modernizing statistical methods for clinical trials: Maryland Wednesday, January 14, 2026, 09:00 Hrs [IST] The US Food and Drug Administration today publ ...
Although population association studies are not new, there remain many areas of disagreement over appropriate statistical analyses. This article provides an overview of statistical methods, including ...
Through tumor profiling and statistical analysis, precision oncology uses genomic and other biomarkers to drive discovery, drug development, and clinical care for patients with cancer. It intends to ...
The product development lifecycle is long and challenging. Whether it is translational research or clinical research, there are numerous obstacles in the design and management of a study and ...
Our lab has developed many data analysis workflows adapting and integrating sophisticated statistical methods to evaluate complex molecular datasets that we obtain with MS technologies. We are ...
High-dimensional -omics data such as genomic, transcriptomic, and metabolomic data offer great promise in advancing precision medicine. In particular, such data have enabled the investigation of ...
Here we offer a 'meta-methodology' and framework in which to evaluate epistemological foundations of proposed statistical methods. On the basis of this framework, we consider that many statistical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results